Agency for Science, Technology and Research (A*STAR), Singapore

Diseases, Conditions, Syndromes

The mutation making SARS-CoV-2 milder

Like any other organism on the planet, the SARS-CoV-2 virus is prone to the natural genetic diversity that may arise from mutations. Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hit the world, there ...

Medical research

The fast track to a 'Fortitude Kit' for rapid COVID-19 diagnosis

It may seem like a lifetime ago, but it was only in late January 2020 that Singapore confirmed its first case of the then-novel coronavirus causing COVID-19. Amid the frenzied atmosphere of the Chinese New Year holidays, ...

Diseases, Conditions, Syndromes

What we know about COVID-19 and how it can be treated

When my team and I first learned about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19), we sprang into action, searching the literature to identify the gaps. In times of ...

Oncology & Cancer

Rethinking breast cancer risk

In October each year, pink ribbons become more prominently displayed on clothing and street corners, the symbol of an international movement to raise awareness about breast cancer. The debilitating disease, which impacts ...


Weaponizing stem cells in the war on diabetes

There's no sugar coating it—diabetes is shaping up to become one of the greatest health challenges in modern times. According to the World Health Organization (WHO), one in eleven individuals suffers from diabetes, and ...

Medical research

Against gut instinct

By turning a pathogenic yeast into an immunity-conferring symbiont, a team of A*STAR researchers is unraveling mysteries behind gut evolution and universal vaccines

page 2 from 40